Warning letter
CIDEC Corporation: warning letter of Oct 31, 2002
FDA warning letter UCM145277 · New York District Office
Key facts
| Reference number | UCM145277 |
|---|---|
| Company | CIDEC Corporation |
| Subject | Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated |
| Issue date | Oct 31, 2002 |
| Posted date | Oct 31, 2002 |
| Issuing office | New York District Office |
| Product type | Drugs |
| CFR sections cited | 211.22, 211.130, 211.188, 211.165(a), 211.165(c), 211.166(a), 211.194(b) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: